Lifevantage (LFVN) Competitors $12.11 -1.35 (-10.03%) Closing price 04:00 PM EasternExtended Trading$12.16 +0.05 (+0.45%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LFVN vs. SIGA, BCAX, VIR, RLAY, KROS, MGTX, MRVI, TYRA, ORGO, and RZLTShould you be buying Lifevantage stock or one of its competitors? The main competitors of Lifevantage include Siga Technologies (SIGA), Bicara Therapeutics (BCAX), Vir Biotechnology (VIR), Relay Therapeutics (RLAY), Keros Therapeutics (KROS), MeiraGTx (MGTX), Maravai LifeSciences (MRVI), Tyra Biosciences (TYRA), Organogenesis (ORGO), and Rezolute (RZLT). These companies are all part of the "pharmaceutical products" industry. Lifevantage vs. Its Competitors Siga Technologies Bicara Therapeutics Vir Biotechnology Relay Therapeutics Keros Therapeutics MeiraGTx Maravai LifeSciences Tyra Biosciences Organogenesis Rezolute Lifevantage (NASDAQ:LFVN) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk. Which has more risk and volatility, LFVN or SIGA? Lifevantage has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Is LFVN or SIGA more profitable? Siga Technologies has a net margin of 45.73% compared to Lifevantage's net margin of 4.12%. Siga Technologies' return on equity of 40.52% beat Lifevantage's return on equity.Company Net Margins Return on Equity Return on Assets Lifevantage4.12% 34.67% 15.24% Siga Technologies 45.73%40.52%35.62% Does the media favor LFVN or SIGA? In the previous week, Lifevantage had 7 more articles in the media than Siga Technologies. MarketBeat recorded 15 mentions for Lifevantage and 8 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.18 beat Lifevantage's score of 0.54 indicating that Siga Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifevantage 4 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Siga Technologies 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, LFVN or SIGA? Siga Technologies has lower revenue, but higher earnings than Lifevantage. Siga Technologies is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifevantage$200.16M0.76$2.94M$0.6917.55Siga Technologies$138.72M4.35$59.21M$1.137.45 Do institutionals and insiders believe in LFVN or SIGA? 35.3% of Lifevantage shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 20.7% of Lifevantage shares are held by company insiders. Comparatively, 2.0% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer LFVN or SIGA? Lifevantage currently has a consensus price target of $30.50, indicating a potential upside of 151.86%. Given Lifevantage's stronger consensus rating and higher probable upside, analysts plainly believe Lifevantage is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifevantage 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySiga Technologies beats Lifevantage on 9 of the 16 factors compared between the two stocks. Get Lifevantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFVN vs. The Competition Export to ExcelMetricLifevantageMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$152.47M$16.05B$5.77B$9.93BDividend Yield1.33%1.51%6.67%4.52%P/E Ratio17.5517.7675.6026.68Price / Sales0.762.43555.18213.69Price / Cash15.3916.1137.1158.92Price / Book5.913.6811.446.09Net Income$2.94M$472.13M$3.28B$266.14M7 Day Performance-7.56%-0.56%0.84%0.27%1 Month Performance-9.90%0.58%7.15%4.13%1 Year Performance34.56%5.19%59.65%23.93% Lifevantage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFVNLifevantage4.3127 of 5 stars$12.11-10.0%$30.50+151.9%+53.3%$152.47M$200.16M17.55260News CoverageGap DownHigh Trading VolumeSIGASiga Technologies2.347 of 5 stars$8.70-4.7%N/A+8.2%$653.76M$138.72M7.7040News CoverageOptions VolumeBCAXBicara Therapeutics2.5942 of 5 stars$11.32-4.4%$32.25+184.9%N/A$646.02MN/A-3.5732Positive NewsVIRVir Biotechnology3.6142 of 5 stars$4.38-4.4%$30.25+590.6%-32.4%$636.24M$74.21M-1.10580News CoverageAnalyst ForecastInsider TradeRLAYRelay Therapeutics2.3964 of 5 stars$3.51-4.9%$17.25+391.5%-37.0%$636.20M$8.36M-1.80330News CoverageAnalyst ForecastKROSKeros Therapeutics3.3714 of 5 stars$14.76-5.1%$30.00+103.3%-70.6%$631.97M$232.84M47.61100News CoveragePositive NewsMGTXMeiraGTx4.5112 of 5 stars$7.58-3.2%$24.00+216.6%+95.9%$629.90M$33.28M-3.72300Positive NewsMRVIMaravai LifeSciences3.6953 of 5 stars$2.40-2.0%$5.75+139.6%-71.1%$625.64M$259.18M-1.76610Positive NewsOptions VolumeTYRATyra Biosciences3.0079 of 5 stars$12.00+2.5%$30.83+156.9%-43.0%$624.11MN/A-6.7420News CoveragePositive NewsAnalyst ForecastORGOOrganogenesis4.2512 of 5 stars$4.67-4.5%$7.50+60.6%+86.3%$620.33M$482.04M-33.35950Positive NewsRZLTRezolute3.1716 of 5 stars$7.00flat$12.20+74.3%+57.0%$608.97MN/A-6.0940News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Siga Technologies Competitors Bicara Therapeutics Competitors Vir Biotechnology Competitors Relay Therapeutics Competitors Keros Therapeutics Competitors MeiraGTx Competitors Maravai LifeSciences Competitors Tyra Biosciences Competitors Organogenesis Competitors Rezolute Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFVN) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifevantage Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifevantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFVN Stock Alerts